LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Syensqo joins EuropaBio: Accelerating Innovation in Biotechnology

05/04/2024

PRESS RELEASE

Brussels, 5 April 2024 - EuropaBio, is very pleased to announce the newest addition to its membership, Syensqo.

With a rich history dating back to 1863 and boasting a global team of 13000+ associates in over 30 countries, Syensqo is inspired by the scientific councils, which were initiated by Ernest Solvay.

Syensqo’s technologies bring benefits to many aspects of daily life. Their innovative solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and health care applications. Their mission is to revolutionise the way we live through their groundbreaking technologies, advancing human progress while cultivating a future for our planet that is not only safer and cleaner, but also inherently more sustainable.

With EuropaBio, Syensqo will help to champion a more sustainable future using biotechnology and biomanufacturing to improve human lives.

Dr. Claire Skentelbery, Director General of EuropaBio had this to say: “We are delighted to welcome Syensqo to the EuropaBio community. It is representative of industrial transition and focus into biotechnology as a fundamental component of future society, economy and sustainability. Together we build Europe’s future.”

Thomas Canova, Executive Vice-President, Head of Renewable Materials & Biotechnology Growth Platform at Syensqo said "Syensqo is proud to join EuropaBio and work alongside other leading companies and experts in biotechnology. We believe that through collaboration and dialogue, we can create a strong European strategy to address the pressing challenges our society is facing today. Joining EuropaBio reflects our commitment to sustainability, innovation, and advancing humanity through biotechnology."

Syensqo joins EuropaBio: Accelerating Innovation in Biotechnology


Download
Share
Adrian Lincoln
Adrian Lincoln

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.